XML 56 R47.htm IDEA: XBRL DOCUMENT v3.22.2
Earnings Per Share - Summary (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (18.4) $ (26.9) $ (6.2) $ (47.9)
Less: Amounts attributable to participating securities 0.0 0.0 0.0 (10.3)
Net loss attributable to common stockholders $ (18.4) $ (26.9) $ (6.2) $ (58.2)
Denominator:        
Weighted average shares outstanding- basic (shares) 88,900 69,267 88,450 62,060
Weighted average shares outstanding- diluted (shares) [1] 88,900 69,267 88,450 62,060
Loss per share:        
Basic (in USD per share) $ (0.21) $ (0.39) $ (0.07) $ (0.94)
Diluted (in USD per share) [1] $ (0.21) $ (0.39) $ (0.07) $ (0.94)
Stock options        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 1,559 2,016 1,599 1,901
Restricted shares        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 628 1,484 644 1,451
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.